GlaxoSmithKline is a finished-dose manufacturer based in United States. It appears in 2,375 regulatory filings across 23 regulators, without an active US DMF or CEP on file. Its filings concentrate with MHRA (UK), Health Canada and SWISSMEDIC (CH). Its GMP standing is certified by TMDA (TZ), NAFDAC (NG) and MFDS (Korea), among 4 authorities.
| Site | FDA FEI |
|---|---|
| Mississauga, United Arab Emirates | Not on file |
| MISSISSAUGA, Canada | Not on file |
| Baar, Switzerland | Not on file |
| TIANJIN, China | Not on file |
| Cairo, Nigeria | Not on file |
| Nairobi, Tanzania | Not on file |
2 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| MHRA (UK) | 863 | 1 |
| Health Canada | 583 | None |
| SWISSMEDIC (CH) | 166 | None |
| DH (HK) | 126 | None |
| EMA | 119 | None |
| ANSM (FR) | 118 | None |
| TMDA (TZ) | None | 4 |
| NAFDAC (NG) | None | 3 |
| MFDS (Korea) | None | 2 |
Choose your molecules and target markets. GlaxoSmithKline comes back tiered against every other supplier able to file there.
Start for free